Sort by

Send to

Choose Destination

Search results

Items: 2


Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches.

Kumar NN, Pizzo ME, Nehra G, Wilken-Resman B, Boroumand S, Thorne RG.

Bioconjug Chem. 2018 Dec 19;29(12):3937-3966. doi: 10.1021/acs.bioconjchem.8b00548. Epub 2018 Oct 24. Review.


Factors Influencing the Central Nervous System Distribution of a Novel Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GSK2126458: Implications for Overcoming Resistance with Combination Therapy for Melanoma Brain Metastases.

Vaidhyanathan S, Wilken-Resman B, Ma DJ, Parrish KE, Mittapalli RK, Carlson BL, Sarkaria JN, Elmquist WF.

J Pharmacol Exp Ther. 2016 Feb;356(2):251-9. doi: 10.1124/jpet.115.229393. Epub 2015 Nov 24.

Supplemental Content

Loading ...
Support Center